围手术期头孢唑林与吲哚美辛用于体格检查指征宫颈环扎术可改善孕周延长
这项回顾性队列研究纳入2009至2018年因体格检查指征行宫颈环扎术的单胎孕妇142例,其中72例(50.7%)接受围手术期头孢唑林和吲哚美辛预防。多因素分析显示,预防组达到孕周延长至少28天的比例更高(aRR 1.21,95%CI 1.05-1.40),且孕周延长天数增加17.8天(95%CI 1.4-34.2天),出生体重增加489.8克(95%CI 64.6-915.0克),未增加绒毛膜羊膜炎等不良结局。
要点
- 围手术期头孢唑林联合吲哚美辛预防与宫颈环扎术后孕周延长显著改善相关。
- 预防组达到孕周延长≥28天的比例更高(aRR 1.21,95%CI 1.05-1.40)。
- 预防组孕周延长增加17.8天,出生体重增加489.8克,未增加绒毛膜羊膜炎。
核心结论
- 体格检查指征宫颈环扎术围手术期使用头孢唑林和吲哚美辛预防与孕周延长显著改善相关,且不增加绒毛膜羊膜炎发生率。
研究设计与样本
- 回顾性队列研究,纳入2009至2018年在美国西北纪念医院因体格检查指征行宫颈环扎术并分娩的单胎孕妇142例,其中72例(50.7%)接受围手术期预防。
- 体格检查指征宫颈环扎术的定义为孕16 0/7至23 6/7周之间无痛性宫颈扩张至少1 cm。
- 2014年后该中心普遍实施围手术期头孢唑林和吲哚美辛预防,按暴露情况分组。
- 主要结局为环扎术后孕周延长至少28天,采用多因素分析及倾向性评分匹配敏感性分析。
主要发现
- 预防组达到孕周延长至少28天的比例更高(校正相对风险[aRR] 1.21,95%CI 1.05-1.40)。
- 预防组孕周延长天数显著增加(+17.8天,95%CI 1.4-34.2天)。
- 预防组出生体重显著增加(+489.8克,95%CI 64.6-915.0克)。
- 两组在其他结局(如28周前早产、未足月胎膜早破、绒毛膜羊膜炎)方面无差异。
- 敏感性分析中,预防组达到孕周延长至少28天的比例仍更高(aRR 1.17,95%CI 1.01-1.36),其他结局无差异。
关键数值与推荐
- 体格检查指征宫颈环扎术适用于孕16 0/7至23 6/7周、无痛性宫颈扩张至少1 cm的单胎孕妇。
- 围手术期预防方案为头孢唑林和吲哚美辛。
- 主要结局指标为环扎术后孕周延长至少28天。
临床怎么用
- 对于符合体格检查指征宫颈环扎术的孕妇,可考虑围手术期使用头孢唑林和吲哚美辛以延长孕周。
- 该预防方案与出生体重增加相关,且未增加绒毛膜羊膜炎风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate gestational latency in individuals who did and did not receive perioperative cefazolin and indomethacin after physical examination-indicated cerclage. METHODS: This is a retrospective cohort study of all pregnant women with a singleton gestation who underwent physical examination-indicated cerclage placement and delivered at Northwestern Memorial Hospital from 2009 to 2018. Physical examination-indicated cerclage was performed in the setting of painless cervical dilation of at least 1 cm between 16 0/7 and 23 6/7 weeks of gestation. After 2014, our practice universally implemented perioperative prophylaxis of cefazolin and indomethacin. Individuals were categorized based on exposure to perioperative prophylaxis. The primary outcome was pregnancy latency at least 28 days after cerclage placement. Secondary outcomes included median latency; median gestational age at delivery; preterm birth before 28 weeks of gestation; preterm prelabor rupture of membranes; chorioamnionitis; and median birth weight. Multivariable analyses were performed, as well as a sensitivity analysis using propensity score matching. RESULTS: Cerclages were placed in 142 people: 72 (50.7%) received perioperative prophylaxis. Baseline demographics were not significantly different between groups. On multivariable analyses, individuals who received perioperative prophylaxis had a higher incidence of achieving a pregnancy latency at 28 days or more (adjusted relative risk [aRR] 1.21, 95% CI 1.05-1.40). Individuals who received perioperative prophylaxis had a significant improvement in gestational latency (+17.8 days, 95% CI 1.4-34.2 days) and birth weight (+489.8 g, 95% CI 64.6-915.0 g), with no differences in other outcomes. On sensitivity analysis, individuals receiving perioperative prophylaxis had a higher incidence of achieving a pregnancy latency at 28 days or more, (aRR 1.17, 95% CI 1.01-1.36) with no differences in other outcomes. CONCLUSION: Perioperative use of cefazolin and indomethacin prophylaxis during physical examination-indicated cerclage placement is associated with a significant prolongation in gestational latency without an increase in incidence of chorioamnionitis.
引用
- Premkumar A, Sinha N, Miller ES, et al. Perioperative Use of Cefazolin and Indomethacin for Physical Examination-Indicated Cerclages to Improve Gestational Latency. Obstet Gynecol. 2020. PMID: 32459433. doi:10.1097/AOG.0000000000003874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。